Interstitial lung disease-related pneumomediastinum in COVID-19 patients

Kim Blanc; Nicolas Bonnet; Elise Ouedraogo; Michel Arnaout; Maxime Patout; Yacine Tandjaoui-Lambiotte

doi:10.1183/23120541.00014-2021

Interstitial lung disease-related pneumomediastinum in COVID-19 patients

ERJ Open Res. 2021 Mar 8;7(1):00014-2021. doi: 10.1183/23120541.00014-2021. eCollection 2021 Jan.

Authors

Kim Blanc^{1

2}, Nicolas Bonnet³, Elise Ouedraogo^{4

5}, Michel Arnaout⁶, Maxime Patout^{7

8}, Yacine Tandjaoui-Lambiotte^{3

9}

Affiliations

¹ Intensive Care Unit, André Grégoire Hospital, Montreuil, France.
² Pulmonology Dept, André Grégoire Hospital, Montreuil, France.
³ Intensive Care Unit, Avicenne Hospital, AP-HP, Bobigny, France.
⁴ Sorbonne Paris Nord University, Bobigny, France.
⁵ Infectious Diseases Dept, Avicenne Hospital, AP-HP, Bobigny, France.
⁶ Intensive Care Unit, Antony Private Hospital, Antony, France.
⁷ Sleep Diseases Dept R3S, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
⁸ INSERM, UMRS1158 Experimental and Clinical Respiratory Neurophysiology, Paris, France.
⁹ INSERM U1272 Hypoxia and Lung, Bobigny, France.

Abstract

Pneumomediastinum in severe #COVID19 presentations could be due to a lung parenchymal retractive process generated by intense inflammation as in acute exacerbation of idiopathic pulmonary fibrosis or MDA-5 acute interstitial lung disease https://bit.ly/3qzBYMW.